Gary W. Unzeitig

General Surgery
6801 McPherson Rd Ste 106
Laredo, TX 78041

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Uptake of Risk-Reducing Surgeries in an International Real-World Cohort of Hispanic Women.

Uptake of Risk-Reducing Surgeries in an International Real-World Cohort of Hispanic Women.

Journal: JCO global oncology
Published: October 31, 2024

Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical Trial.

Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical Trial.

Journal: JAMA oncology
Published: January 18, 2024

Local-Regional Recurrence After Neoadjuvant Endocrine Therapy: Data from ACOSOG Z1031 (Alliance), a Randomized Phase 2 Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2 or 3 Breast Cancer.

Local-Regional Recurrence After Neoadjuvant Endocrine Therapy: Data from ACOSOG Z1031 (Alliance), a Randomized Phase 2 Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2 or 3 Breast Cancer.

Journal: Annals of surgical oncology
Published: September 02, 2022

The Influence of Vitamin D on Mammographic Density: Results from CALGB 70806 (Alliance) a Randomized Clinical Trial.

The Influence of Vitamin D on Mammographic Density: Results from CALGB 70806 (Alliance) a Randomized Clinical Trial.

Journal: Cancer prevention research (Philadelphia, Pa.)
Published: November 07, 2020

Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families.

Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 17, 2019

Clinical Trials for the Surgical Oncologist: Opportunities and Hurdles.

Clinical Trials for the Surgical Oncologist: Opportunities and Hurdles.

Journal: Annals of surgical oncology
Published: December 13, 2019

Health-related quality of life outcomes for the LEAP study-CALGB 70305 (Alliance): A lymphedema prevention intervention trial for newly diagnosed breast cancer patients.

Health-related quality of life outcomes for the LEAP study-CALGB 70305 (Alliance): A lymphedema prevention intervention trial for newly diagnosed breast cancer patients.

Journal: Cancer
Published: August 22, 2019

A randomized study to prevent lymphedema in women treated for breast cancer: CALGB 70305 (Alliance).

A randomized study to prevent lymphedema in women treated for breast cancer: CALGB 70305 (Alliance).

Journal: Cancer
Published: June 17, 2019

Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.

Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.

Journal: Cancer
Published: September 21, 2018

Disease-Free and Overall Survival Among Patients With Operable HER2-Positive Breast Cancer Treated With Sequential vs Concurrent Chemotherapy: The ACOSOG Z1041 (Alliance) Randomized Clinical Trial.

Disease-Free and Overall Survival Among Patients With Operable HER2-Positive Breast Cancer Treated With Sequential vs Concurrent Chemotherapy: The ACOSOG Z1041 (Alliance) Randomized Clinical Trial.

Journal: JAMA oncology
Published: September 08, 2018

Hispanic breast cancer patients' symptom experience and patient-physician communication during chemotherapy.

Hispanic breast cancer patients' symptom experience and patient-physician communication during chemotherapy.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: February 12, 2018

Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trial.

Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 29, 2017
Showing 1-12 of 16

Last Updated: 09/26/2026